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Dear Editor, 
 
Indole-3-carbinol (I3C; C9H9NO) is a phytochemical that is derived from the breakdown of 
the glucosinolate, glucobrassicin. I3C is present at relatively high levels in most cruciferous 
vegetables such as broccoli, cabbage, cauliflower, brussels sprouts, collard greens, and kale 
(Fujioka et al., 2016; Licznerska and Baer-Dubowska, 2016). The enzyme, myrosinase (β-thi-
oglucosidase), catalyzes the hydrolysis of glucosinolates in intact plant cells (Zhao et al., 2015). 
After chopping or chewing of raw cruciferous vegetables, the plant cells are damaged and glu-
cobrassicin is exposed to myrosinase. This catalyzes the conversion of glucobrassicin to a glu-
cose molecule and an unstable aglycone, which is hydrolyzed to thiohydroximate-O-sulfonate 
(de Vos et al., 2008). If the sulfate ion is released spontaneously, this may form another unstable 
intermediate, 3-indolylmethylisothiocyanate. This released compound readily converts to a thi-
ocyanate ion and I3C (Kim et al., 2008).  
I3C has recently become available as a nutritional supplement and it provides an attractive 
natural product for drug development in the pharmaceutical industry. It has been reported to 
show diverse promising biological properties, with anti-atherogenic, antioxidant, anti-carcino-
genic, and anti-inflammatory activities (Fuentes et al., 2015; Maruthanila et al., 2014). I3C has 
attracted considerable attention in recent years within the pharmaceutical and functional food 
industries. Here, we summarize recent studies performed to evaluate the biological and phar-
macological activities of I3C (Table 1).  
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Table 1: Recent studies on the biological and pharmacological activities of Indole-3-carbinol 
Key findings Reference 
I3C produced anti-leukemic effects through aryl hydrocarbon receptor activa-
tion, which is associated with programmed cell death and G1 cell cycle ar-
rest. This could provide a novel treatment possibility in acute myeloid leuke-
mia. 
Mohammadi et al., 
2017 
I3C reduced the expression of endothelial and leukocytic adhesion proteins, 
resulting in attenuated leukocyte-endothelial cell interactions during ische-
mia-reperfusion. Accordingly, dietary supplements containing I3C may be 
beneficial for the treatment of ischemia-reperfusion-induced inflammation. 
Ampofo et al., 2017 
I3C feeding attenuated the symptoms of peanut allergy. This dietary com-
pound could therefore positively influence vital immune functions within the 
gut. 
Hammerschmidt-
Kamper et al., 2017 
The oncogenic signal transducer and activator of transcription 5/Akt pathway 
was a cellular target for I3C in chronic myeloid leukemia cells. Safa et al., 2017 
Combined application of linagliptin and I3C significantly improved ovarian 
morphology in a polycystic ovarian syndrome group. Combined use of these 
compounds was more effective than either drug alone. Combined application 
of linagliptin/I3C could contribute to the amelioration of this condition. 
Kabel et al., 2017 
This preliminary structure-activity relationship study of a series including I3C 
and closely related compounds identified a potent lead compound with low 
micromolar activity against a particularly resistant glioblastoma cell line, sug-
gesting a new platform for future development of a novel therapy in this area. 
Sherer et al., 2017 
Nano-capsules formulated with rose hip oil increased the antitumor effects of 
I3C on breast cancer (MCF-7) and glioma (C6) cells by about two-fold, with-
out a significant reduction in astrocyte cell viability. This formulation might 
represent a promising innovation for cancer treatment. 
Gehrcke et al., 
2017 
A novel set of anti-cancer compounds were derived from I3C analogues. 
These could be used to treat human melanomas and other cancers express-
ing indolecarbinol-sensitive target enzymes. 
Quirit et al., 2017 
Hazardous effects of I3C supplementation on the gastrointestinal tract in an 
immuno-compromised model were reported, indicating that caution is war-
ranted when using I3C as a dietary supplement. 
Fletcher et al., 2017 
I3C reduced the impact of Clostridium difficile infection in mice via both aryl 
hydrocarbon receptor-dependent and -independent mechanisms. Dietary 
supplementation of I3C could provide a potential therapy for the prevention 
and amelioration of C. difficile infection. 
Julliard et al., 2017 
 
The oncogenic BRAF V600E mutation is considered to represent a cellular 
target of I3C, indicating that this compound is a potential candidate for novel 
mono- or combination therapies for melanoma. 
Kundu et al., 2017 
Lipid droplet accumulation in adipocytes was reduced by I3C and adipocyte-
stimulated angiogenesis was suppressed in endothelial cells. This suggested 
that I3C could provide a potential therapeutic agent for obesity and obesity-
associated disorders. 
Wang et al., 2016 
The molecular mechanism underlying the effects of I3C in colorectal cancer 
may be novel. Continued preclinical studies of both I3C and the aryl hydro-
carbon receptor pathway are required, and may lead to novel diet-derived 
treatments for colon cancer. 
Megna et al., 2016 
I3C reduced cisplatin-induced nephrotoxicity. This compound reduced the 
expression of calcitonin gene-related peptide; this may play a positive role in 
the pathogenesis of cisplatin-induced renal injury. 
El-Naga and Mah-
ran, 2016 
I3C inhibited estradiol-mediated stimulation of rat osteoblast proliferation and 
differentiation and increased the 2-hydroxylation of estrone, thus promoting 
the formation of inactive and anti-estrogenic metabolites. These findings sug-
gested that the anti-estrogenic effect of I3C is mediated by 2-hydroxy estra-
diol via the estrogen receptor α in neonatal rat osteoblasts. 
Enríquez et al., 
2016 
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Key findings Reference 
Acetylsalicylic acid (aspirin)-mediated regulation of Wnt signaling and I3C-
targeted signaling pathways converged at distinct DNA elements within the 
microphthalmia-associated transcription factor isoform M promoter, disrupt-
ing the expression of this gene and thus modulating melanoma cell prolifera-
tion. 
Poindexter et al., 
2016 
I3C plus silibinin acted as a potential lung cancer chemopreventive agent in 
smokers/former smokers with chronic pulmonary inflammatory conditions. Song et al., 2015 
I3C reduced the cytotoxicity of dexamethasone by blocking the over-accumu-
lation of reactive oxygen species and enhancing the expression of Nrf2. The 
findings of this study could provide a sustainable strategy for molecular inter-
vention in glucocorticoid-induced osteoporosis, using natural products. 
Lin et al., 2015 
I3C was reported to suppress the acute hepatic inflammation caused by 
staphylococcal enterotoxin B; this was mediated by decreasing the expres-
sion of miR-31, and subsequent caspase-2-dependent apoptosis in T cells. 
Busbee et al., 2015 
I3C was used in combination with anthracyclines in acute lymphoblastic leu-
kemia, providing a new insight into the development of a novel combination 
therapy for this condition. 
Safa et al., 2015 
I3C was used as a miR-21 regulator, leading to repression of the phospha-
tase and tensin homolog/Akt pathway, which might provide a new approach 
to the eradication of drug-resistant cells. This could improve therapeutic out-
comes in patients diagnosed with hepatocellular carcinoma. 
Wang et al., 2015 
Estrogen receptor α signaling enhanced the pro-apoptotic effect of I3C-medi-
ated induction of the aryl hydrocarbon receptor in luminal breast cancer cell 
lines; this involved oxidative stress-induced upregulation of ATF-3 (activating 
transcription factor 3)  and the downstream protein, BH3 (Bcl-2 homology3). 
Caruso et al., 2014 
I3C and its condensation dimer (3,3'-diindolylmethane) extended survival and 
reduced tumor burdens in mice with Epstein-Barr virus-positive Burkitt’s lym-
phoma (DAUDI) cells. 
Perez-Chacon et 
al., 2014 
The E3 ubiquitin-protein ligase, NEDD4-1, was identified as a new I3C target 
protein. I3C disrupted this enzyme activity, triggering stabilization of a tumor 
suppressor (wild-type phosphatase and tensin homologue detected on chro-
mosome 10) and thus inducing an antiproliferative response in melanoma. 
Aronchik et al.,  
2014 
Exposure to low levels of I3C increased adenovirus-mediated oncolysis and 
cytotoxicity in human carcinoma cells via synergistic upregulation of apopto-
sis. A dietary supplement containing I3C may help to prevent cancer and im-
prove oncolytic therapies. 
Chen et al., 2014 
I3C produced an anti-adipogenic effect in zebrafish. This study suggested 
that I3C could reduce lipid accumulation within cells via several molecular 
mechanisms.  
Choi et al., 2014 
The growth of nasopharyngeal carcinoma cells was reduced by I3C, which 
induced apoptosis both in vivo and in vitro. This study suggested that I3C 
suppressed the phosphatidylinositol 3-kinase/Akt pathway. 
Mao et al., 2014 
Antioxidant scavenging was enhanced in mice treated with 3,3'-diindolylme-
thane; this effect was greater than that of I3C, which was comparable to the 
standard drug, metformin. 
Jayakumar et al., 
2014 
Maternal I3C feeding during pregnancy protected male offspring exposed to 
bisphenol A, indicating a reduction of harmful effects on the prostate. Brandt et al., 2014 
Plant-derived indoles were potent suppressors of staphylococcal enterotoxin 
B-induced T cell activation and cytokine production; they may mediate these 
effects by acting as histone deacetylase inhibitors. 
Busbee et al., 2014 
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